180 related articles for article (PubMed ID: 28685676)
1. Recent Advances in Superparamagnetic Iron Oxide Based Nanoprobes as Multifunctional Theranostic Agents for Breast Cancer Imaging and Therapy.
Zheng J; Ren W; Chen T; Jin Y; Li A; Yan K; Wu Y; Wu A
Curr Med Chem; 2018; 25(25):3001-3016. PubMed ID: 28685676
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapy.
Yang RM; Fu CP; Fang JZ; Xu XD; Wei XH; Tang WJ; Jiang XQ; Zhang LM
Int J Nanomedicine; 2017; 12():197-206. PubMed ID: 28096667
[TBL] [Abstract][Full Text] [Related]
4. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
5. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
6. 2D Superparamagnetic Tantalum Carbide Composite MXenes for Efficient Breast-Cancer Theranostics.
Liu Z; Lin H; Zhao M; Dai C; Zhang S; Peng W; Chen Y
Theranostics; 2018; 8(6):1648-1664. PubMed ID: 29556347
[No Abstract] [Full Text] [Related]
7. Phosphocholine-decorated superparamagnetic iron oxide nanoparticles: defining the structure and probing in vivo applications.
Luchini A; Irace C; Santamaria R; Montesarchio D; Heenan RK; Szekely N; Flori A; Menichetti L; Paduano L
Nanoscale; 2016 May; 8(19):10078-86. PubMed ID: 26751053
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
9. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
10. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
12. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
Hu Y; Mignani S; Majoral JP; Shen M; Shi X
Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB; Ulrih NP
Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Mahmoudi M; Sant S; Wang B; Laurent S; Sen T
Adv Drug Deliv Rev; 2011; 63(1-2):24-46. PubMed ID: 20685224
[TBL] [Abstract][Full Text] [Related]
15. Iron Oxide Nanoparticles for Breast Cancer Theranostics.
Shakil MS; Hasan MA; Sarker SR
Curr Drug Metab; 2019; 20(6):446-456. PubMed ID: 30465497
[TBL] [Abstract][Full Text] [Related]
16. Manganese doped iron oxide theranostic nanoparticles for combined T1 magnetic resonance imaging and photothermal therapy.
Zhang M; Cao Y; Wang L; Ma Y; Tu X; Zhang Z
ACS Appl Mater Interfaces; 2015 Mar; 7(8):4650-8. PubMed ID: 25672225
[TBL] [Abstract][Full Text] [Related]
17. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
18. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Bakhtiary Z; Saei AA; Hajipour MJ; Raoufi M; Vermesh O; Mahmoudi M
Nanomedicine; 2016 Feb; 12(2):287-307. PubMed ID: 26707817
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
20. Superparamagnetic Iron Oxide Nanorod Carriers for Paclitaxel Delivery in the Treatment and Imaging of Colon Cancer in Mice.
Dehvari K; Chen Y; Tsai YH; Tseng SH; Lin KS
J Biomed Nanotechnol; 2016 Sep; 12(9):1734-45. PubMed ID: 29345885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
